Efficacy and Safety of Bevacizumab in Pretreated Metastatic Breast Cancer: A Systematic Review and Meta-Analysis

BACKGROUND: The use of bevacizumab in patients with previously treated metastatic breast cancer (MBC) is controversial. This meta-analysis was carried out to evaluate the efficacy and safety of the regimen including bevacizumab among patients with pretreated MBC. METHODS: We systematically searched...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhijun, Guo, Fengzhu, Han, Yiqun, Wang, Jiayu, Xu, Binghe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677857/
https://www.ncbi.nlm.nih.gov/pubmed/35882206
http://dx.doi.org/10.1159/000525882

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677857/
https://www.ncbi.nlm.nih.gov/pubmed/35882206
http://dx.doi.org/10.1159/000525882

Ejemplares similares